Skip to content
Home » Ascendis Pharma A/S (ASND) Faced R&D Setbacks in Q4

Ascendis Pharma A/S (ASND) Faced R&D Setbacks in Q4

    Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The final quarter of 2023 saw a continuous fluctuation between recessionary fears and soft-landing optimism. In the fourth quarter, the fund’s Investor Class fund ARTMX returned 8.86%, Advisor Class fund APDMX […]

    Read full NASCAR article on Yahoo Sports

    Read all NASCAR articles